NCT06229275 Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Collection
| NCT ID | NCT06229275 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Morehouse School of Medicine |
| Condition | Cervical Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-07-25 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-07-25 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This purpose of this research study is to determine the effectiveness of the Personal Pap Smear Device™ to collect adequate cervical cell samples for cytology examination when compared with the Rover Cervex-Brush (Cervix-Examination Brush).
Eligibility Criteria
Inclusion Criteria: * Adult women, aged 21-65 years old. * Do not have any medical or psychiatric condition affecting the ability to give voluntary informed consent. * Be able to read and understand English Exclusion Criteria: * Participants currently on menses * Inability to provide Informed Consent * Previous total hysterectomy * History of radiation treatment for cervical cancer * Pregnancy * Medical condition that interferes with conduct of study, in investigator's opinion * Evidence of active cervical infection requiring treatment * Known bleeding diathesis
Contact & Investigator
Regina K Leonis, MD, MD
PRINCIPAL INVESTIGATOR
Morehouse School of Medicine
Frequently Asked Questions
Who can join the NCT06229275 clinical trial?
This trial is open to female participants only, aged 21 Years or older, up to 65 Years, studying Cervical Cancer Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06229275 currently recruiting?
Yes, NCT06229275 is actively recruiting participants. Contact the research team at rleonis@msm.edu for enrollment information.
Where is the NCT06229275 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT06229275 clinical trial?
NCT06229275 is sponsored by Morehouse School of Medicine. The principal investigator is Regina K Leonis, MD, MD at Morehouse School of Medicine. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.